标题
High-dose ascorbic acid synergizes with anti-PD1 in a lymphoma mouse model
作者
关键词
-
出版物
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 117, Issue 3, Pages 1666-1677
出版商
Proceedings of the National Academy of Sciences
发表日期
2020-01-08
DOI
10.1073/pnas.1908158117
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Ascorbic acid–induced TET activation mitigates adverse hydroxymethylcytosine loss in renal cell carcinoma
- (2019) Niraj Shenoy et al. JOURNAL OF CLINICAL INVESTIGATION
- LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade
- (2018) Wanqiang Sheng et al. CELL
- Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors
- (2018) Kristian M. Hargadon et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes
- (2018) Naval Daver et al. LEUKEMIA
- Human endogenous retroviruses and their implication for immunotherapeutics of cancer
- (2018) A S Attermann et al. ANNALS OF ONCOLOGY
- Ascorbic Acid in Cancer Treatment: Let the Phoenix Fly
- (2018) Niraj Shenoy et al. CANCER CELL
- Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade
- (2018) Joy Hsu et al. JOURNAL OF CLINICAL INVESTIGATION
- Vitamin C and immune cell function in inflammation and cancer
- (2018) Abel Ang et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer Therapy
- (2018) Matthew M. Gubin et al. CELL
- Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12
- (2018) Christopher S. Garris et al. IMMUNITY
- TET2 deficiency causes germinal center hyperplasia, impairs plasma cell differentiation and promotes B-cell lymphomagenesis
- (2018) Pilar M Dominguez et al. Cancer Discovery
- Drugs with anti-oxidant properties can interfere with cell viability measurements by assays that rely on the reducing property of viable cells
- (2017) Niraj Shenoy et al. LABORATORY INVESTIGATION
- Ascorbate regulates haematopoietic stem cell function and leukaemogenesis
- (2017) Michalis Agathocleous et al. NATURE
- PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
- (2017) Sydney R. Gordon et al. NATURE
- Inhibiting DNA methylation activates cancer testis antigens and expression of the antigen processing and presentation machinery in colon and ovarian cancer cells
- (2017) Cornelia Siebenkäs et al. PLoS One
- Immunological effects of hypomethylating agents
- (2017) Katherine E. Lindblad et al. Expert Review of Hematology
- Upregulation of TET activity with ascorbic acid induces epigenetic modulation of lymphoma cells
- (2017) N Shenoy et al. Blood Cancer Journal
- Vitamin C increases viral mimicry induced by 5-aza-2′-deoxycytidine
- (2016) Minmin Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Proteasome Inhibitor YSY01A Enhances Cisplatin Cytotoxicity in Cisplatin-Resistant Human Ovarian Cancer Cells
- (2016) Wei Huang et al. Journal of Cancer
- DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts
- (2015) David Roulois et al. CELL
- Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses
- (2015) Katherine B. Chiappinelli et al. CELL
- PD-1 expression on dendritic cells suppresses CD8+ T cell function and antitumor immunity
- (2015) Tong Seng Lim et al. OncoImmunology
- Vitamin C treatment of mouse bone marrow-derived dendritic cells enhanced CD8+ memory T cell production capacity of these cells in vivo
- (2014) Young-Joo Jeong et al. IMMUNOBIOLOGY
- IL-12 Produced by Dendritic Cells Augments CD8+ T Cell Activation through the Production of the Chemokines CCL1 and CCL17
- (2014) C. J. Henry et al. JOURNAL OF IMMUNOLOGY
- 5-Azacytidine Promotes an Inhibitory T-Cell Phenotype and Impairs Immune Mediated Antileukemic Activity
- (2014) Thomas Stübig et al. MEDIATORS OF INFLAMMATION
- Dissecting the dynamic changes of 5-hydroxymethylcytosine in T-cell development and differentiation
- (2014) A. Tsagaratou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- High-Dose Parenteral Ascorbate Enhanced Chemosensitivity of Ovarian Cancer and Reduced Toxicity of Chemotherapy
- (2014) Y. Ma et al. Science Translational Medicine
- 5-Azacytidine treatment sensitizes tumor cells to T-cell mediated cytotoxicity and modulates NK cells in patients with myeloid malignancies
- (2014) A O Gang et al. Blood Cancer Journal
- Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents
- (2013) H Yang et al. LEUKEMIA
- Genome-wide hydroxymethylation tested using the HELP-GT assay shows redistribution in cancer
- (2013) Sanchari Bhattacharyya et al. NUCLEIC ACIDS RESEARCH
- Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer
- (2011) Michael Graham Espey et al. FREE RADICAL BIOLOGY AND MEDICINE
- The biology of cancer testis antigens: Putative function, regulation and therapeutic potential
- (2011) Elisabetta Fratta et al. Molecular Oncology
- PTD4-apoptin protein and dacarbazine show a synergistic antitumor effect on B16-F1 melanoma in vitro and in vivo
- (2010) Jia-lu Jin et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Azacytidine impairs NK cell reactivity while decitabine augments NK cell responsiveness toward stimulation
- (2010) Benjamin J. Schmiedel et al. INTERNATIONAL JOURNAL OF CANCER
- Demethylating treatment suppresses natural killer cell cytolytic activity
- (2009) Xiao-ning Gao et al. MOLECULAR IMMUNOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started